If you are exploring options beyond medication for ongoing depressive symptoms, you may be considering NeuroStar transcranial magnetic stimulation (TMS). At Chrysalis Psychiatry, our providers use evidence-based criteria to determine whether this non-invasive therapy may be appropriate for you. We make decisions based on your condition and symptoms, your treatment history, and your overall health profile. Understanding the conditions treated by NeuroStar TMS therapy can help patients in Santa Fe make informed decisions as you consider next steps.
The primary condition we treat with NeuroStar TMS therapy is major depressive disorder (MDD). Our providers consider this treatment for patients age 15 and up who have not experienced sufficient improvement from antidepressant medications.
The FDA has cleared NeuroStar TMS for this use based on clinical trials that demonstrated meaningful symptom improvement for many individuals who did not respond adequately to medication alone. This makes NeuroStar TMS an important care option when you are facing persistent depressive symptoms despite prior treatment efforts.
NeuroStar is also cleared for those with anxious depression, aged 22 and up.
The FDA has also cleared NeuroStar TMS as an adjunct therapy for obsessive-compulsive disorder in adults. Adjunct means that you should continue with structured behavioral interventions alongside TMS treatment.
Growing research shows that targeted magnetic stimulation may influence brain circuits involved in repetitive thoughts and behaviors, as well as depression generating brain circuits. If you have obsessive-compulsive disorder, we will consider your candidacy for this treatment with careful assessment.
Our providers understand that—while research continues into NeuroStar TMS therapy for additional conditions—it is currently only cleared for major depressive disorder, anxious depression, and obsessive-compulsive disorder.
You may encounter online discussions about TMS for anxiety disorders, post-traumatic stress disorder, or bipolar depression. However, these uses are still being studied and are not part of current regulatory clearance. Our providers rely on established evidence and regulatory guidance when recommending care.
Before recommending NeuroStar TMS therapy, our providers will conduct a detailed evaluation to confirm your diagnosis and ensure the therapy aligns with your needs. This process typically includes a review of your current symptoms and diagnostic history, discussion of prior medication, and an assessment of medical and neurological considerations. This structured approach ensures that we only consider NeuroStar TMS as a treatment option when it matches both the condition being treated and a Santa Fe patient’s individual circumstances.
We usually schedule treatment sessions five days per week over 6-7 weeks. While you may notice mild scalp discomfort or tapping sensations during sessions, these effects often decrease over time. Our providers will monitor your response throughout your NeuroStar TMS treatment course and make adjustments as needed to support your comfort while treating your condition.
At Chrysalis Psychiatry, our providers focus on ensuring your customized care is grounded in clinical evidence. If NeuroStar TMS is appropriate for your condition, our care team will guide you through each step with ongoing support.
Santa Fe patients can call us today if you are still wondering about conditions treated by NeuroStar TMS therapy. We will help you take the first step toward understanding whether this therapy aligns with your diagnosis and treatment goals.
